Profiel
Anthony J.
Bolton is Director at Immodulon Therapeutics Ltd. since 2015.
Formerly, Mr. Bolton was President of Investments at FIL Investment Advisors (UK) Ltd. from 2009 to 2010 and Portfolio Manager at FIL Investment Management (Hong Kong) Ltd. from 2010 to 2014.
Actieve functies van Anthony Bolton
| Bedrijven | Functie | Begin |
|---|---|---|
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Develops treatments for cancer | Directeur/Bestuurslid | 01-01-2015 |
Eerdere bekende functies van Anthony Bolton
| Bedrijven | Functie | Einde |
|---|---|---|
FIL Investment Management (Hong Kong) Ltd.
FIL Investment Management (Hong Kong) Ltd. Investment ManagersFinance FIL-HK employs an active, bottom-up, fundamental research-based investment approach which aims to uncover mispricing to add value to investments. Their analysts undertake extensive first-hand company research. They give portfolio managers discretion in their choice of management style. The portfolio managers meet with peers and senior members of the investment team to review performance and chart strategies for stock selection. The firm shares a proprietary global communications network with Fidelity Management, enabling their portfolio managers, research analysts and traders around the world to instantly distribute the latest corporate developments and research findings to each other and to their Fidelity Management counterparts. | Portefeuillebeheerder-Aandelen | 01-04-2014 |
FIL Investment Advisors (UK) Ltd.
FIL Investment Advisors (UK) Ltd. Investment ManagersFinance FIA UK is an active manager which aims to achieve long-term capital appreciation through a bottom-up approach. They focus on individual companies that seek to identify fundamental value in stocks. The firm uses a wide variety of investment strategies in managing client assets. FIA-UK conducts fundamental research, focusing on business franchise, trading environment, valuation, and management. Top-down considerations complement their approach, with attention paid to political, environmental and social issues likely to impact on a company's potential. | Portefeuillebeheerder-Aandelen | 25-08-2009 |
FIL Ltd.
FIL Ltd. Investment ManagersFinance Provides investment advice | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
FIL Ltd.
FIL Ltd. Investment ManagersFinance Provides investment advice | Finance |
FIL Investment Advisors (UK) Ltd.
FIL Investment Advisors (UK) Ltd. Investment ManagersFinance FIA UK is an active manager which aims to achieve long-term capital appreciation through a bottom-up approach. They focus on individual companies that seek to identify fundamental value in stocks. The firm uses a wide variety of investment strategies in managing client assets. FIA-UK conducts fundamental research, focusing on business franchise, trading environment, valuation, and management. Top-down considerations complement their approach, with attention paid to political, environmental and social issues likely to impact on a company's potential. | Finance |
FIL Investment Management (Hong Kong) Ltd.
FIL Investment Management (Hong Kong) Ltd. Investment ManagersFinance FIL-HK employs an active, bottom-up, fundamental research-based investment approach which aims to uncover mispricing to add value to investments. Their analysts undertake extensive first-hand company research. They give portfolio managers discretion in their choice of management style. The portfolio managers meet with peers and senior members of the investment team to review performance and chart strategies for stock selection. The firm shares a proprietary global communications network with Fidelity Management, enabling their portfolio managers, research analysts and traders around the world to instantly distribute the latest corporate developments and research findings to each other and to their Fidelity Management counterparts. | Finance |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Develops treatments for cancer | Health Technology |
















